[Recurrent erysipelas]. 1991

C Dangoisse, and M Ledoux
Clinique Dermatologique, Hôpitaux universitaire, Sain-Pierre.

Erysipelas is clinically defined as a febrile skin infection with a sudden onset of a red indurated expanding plaque with distinct border. A typical erysipelas presents various degrees of cutaneous erythema, oedema and is characterized by less well-defined margins. The responsible agent can be a beta-hemolytic streptococcus (group A), Staphylococcus aureus and other streptococci (group B, C and D). Common predisposing factors are venous insufficiency, lymphatic obstruction and underlying illnesses. Guidelines for the diagnosis and the management of erysipelas are proposed. The episodes of erysipelas ordinarily respond promptly to penicillin or a beta-lactamase resistant antibiotic. Prevention of recurrent erysipelas by means of an antibiotic prophylaxis is discussed.

UI MeSH Term Description Entries
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004886 Erysipelas An acute infection of the skin caused by species of STREPTOCOCCUS. This disease most frequently affects infants, young children, and the elderly. Characteristics include pink-to-red lesions that spread rapidly and are warm to the touch. The commonest site of involvement is the face.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012874 Skin Diseases, Infectious Skin diseases caused by bacteria, fungi, parasites, or viruses. Infectious Skin Diseases,Disease, Infectious Skin,Diseases, Infectious Skin,Infectious Skin Disease,Skin Disease, Infectious

Related Publications

C Dangoisse, and M Ledoux
July 1967, Medizinische Klinik,
C Dangoisse, and M Ledoux
January 2010, Presse medicale (Paris, France : 1983),
C Dangoisse, and M Ledoux
February 1972, Srpski arhiv za celokupno lekarstvo,
C Dangoisse, and M Ledoux
May 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
C Dangoisse, and M Ledoux
January 1948, Ceskoslovenska dermatologie,
C Dangoisse, and M Ledoux
January 1993, Nederlands tijdschrift voor geneeskunde,
C Dangoisse, and M Ledoux
January 1993, Nederlands tijdschrift voor geneeskunde,
C Dangoisse, and M Ledoux
April 1960, The Journal of obstetrics and gynaecology of the British Empire,
C Dangoisse, and M Ledoux
January 1993, Nederlands tijdschrift voor geneeskunde,
C Dangoisse, and M Ledoux
January 1925, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!